Loading company…
Vesicure Therapeutics develops early-stage exosome drugs and drug delivery technology.
Founded in 2021 and based in Suzhou, China, Vesicure Therapeutics develops exosome drugs and an innovative exosome drug research platform. The company plans to establish a modEXOTM engineered exosome drug delivery platform.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in